Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group (Q72092912)
Jump to navigation
Jump to search
scientific article published on 01 August 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group |
scientific article published on 01 August 1994 |
Statements
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group (English)
U Thadani
M Ezekowitz
L Fenney
1 August 1994